Occudo Quantitative Strategies LP Acquires 15,894 Shares of PetMed Express, Inc. (NASDAQ:PETS)

Occudo Quantitative Strategies LP raised its holdings in shares of PetMed Express, Inc. (NASDAQ:PETS) by 70.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 38,597 shares of the company’s stock after buying an additional 15,894 shares during the quarter. Occudo Quantitative Strategies LP’s holdings in PetMed Express were worth $186,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of PETS. R Squared Ltd bought a new position in PetMed Express during the fourth quarter valued at $31,000. Quarry LP bought a new position in PetMed Express during the fourth quarter valued at $47,000. Virtu Financial LLC bought a new position in PetMed Express during the fourth quarter valued at $58,000. Boothbay Fund Management LLC bought a new position in PetMed Express during the fourth quarter valued at $59,000. Finally, Diametric Capital LP bought a new position in PetMed Express during the fourth quarter valued at $86,000. Institutional investors own 73.33% of the company’s stock.

PetMed Express Trading Up 2.7%

Shares of PETS opened at $3.86 on Friday. PetMed Express, Inc. has a twelve month low of $2.90 and a twelve month high of $6.85. The company has a market cap of $79.73 million, a P/E ratio of 386.39 and a beta of 0.76. The company’s fifty day simple moving average is $3.62 and its 200-day simple moving average is $4.43.

Analyst Ratings Changes

Several equities analysts have commented on PETS shares. StockNews.com lowered shares of PetMed Express from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. Morgan Stanley reduced their target price on shares of PetMed Express from $3.50 to $3.20 and set an “underweight” rating on the stock in a research note on Thursday, April 17th.

Insider Activity

In other news, CEO Sandra Yvette Campos sold 60,463 shares of the company’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $3.31, for a total value of $200,132.53. Following the transaction, the chief executive officer now directly owns 578,524 shares in the company, valued at approximately $1,914,914.44. This represents a 9.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.10% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.